European Commission Conducts Stress Test in Wake of Pip Breast Implant Scandal

L'affaire Pip: the European Commission calls for immediate measures to strengthen the existing surveillance and safety controls on medical devices already on the market.

February 3, 2012

1 Min Read
European Commission Conducts Stress Test in Wake of Pip Breast Implant Scandal

On the heels of a scientific study on faulty breast implants manufactured by French company Poly Implant Prothèse (Pip), the European Commission (EC) has called for a "series of immediate measures to strengthen the existing surveillance and safety controls on medical devices already on the market," according to Health and Consumers Commissioner John Dalli. In a press release issued on 2 February by the EC, Dalli also noted  that a "stress test of legislation on medical devices is underway in order to identify how best the questions raised by this issue can be addressed in the revision of [the medical device directives]."

For more about this study and its potential impact on the medical technology industry, see my blog post on emdt.co.uk.

Norbert Sparrow

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like